Andere Kunden interessierten sich auch für
![Advancing Progress in the Development of Combination Cancer Therapies with Immune Checkpoint Inhibitors]( "Advancing Progress in the Development of Combination Cancer Therapies with Immune Checkpoint Inhibitors")
Advancing Progress in the Development of Combination Cancer Therapies with Immune Checkpoint Inhibitors66,99 €![Refining Processes for the Co-Development of Genome-Based Therapeutics and Companion Diagnostic Tests]( "Refining Processes for the Co-Development of Genome-Based Therapeutics and Companion Diagnostic Tests")
Refining Processes for the Co-Development of Genome-Based Therapeutics and Companion Diagnostic Tests39,99 €![Understanding the Role of the Immune System in Improving Tissue Regeneration]( "Understanding the Role of the Immune System in Improving Tissue Regeneration")
Understanding the Role of the Immune System in Improving Tissue Regeneration44,99 €![Selected Immune Disorders and Disability]( "Selected Immune Disorders and Disability")
Selected Immune Disorders and Disability39,99 €![Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development]( "Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development")
Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development35,99 €![Addressing the Needs of an Aging Population Through Health Professions Education]( "Addressing the Needs of an Aging Population Through Health Professions Education")
Addressing the Needs of an Aging Population Through Health Professions Education26,99 €![Antibiotic Resistance]( "Antibiotic Resistance")
Antibiotic Resistance109,99 €
The use of immune modulator therapeutics, a type of immunotherapy enhancing the body immune system response to cancer, was perceived as the beginning of a new era in cancer care. While still important and frequently used, some of these therapeutics produce uneven response rates, disease resistance, and serious side effects. The National Academies National Cancer Policy Forum, in collaboration with the Forum on Drug Discovery, Development, and Translation, hosted a public workshop to discuss challenges related to immunotherapy treatment resistance, as well as potential policy opportunities to improve the development of immunotherapies for cancer treatment.